Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal

Maurizio A. Leone, G. C. Avanzi, A. Lo Iacono, F. Vigna-Taglianti, F. Faggiano

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy and safety of GHB in prevention and treatment of the AWS, more specifically • to compare the efficacy of GHB with placebo or other drugs; • to identify the most effective GHB dosage and schedules; • to estimate the incidence of side effects; • to carry out a risk-benefit analysis. ...

Original languageEnglish
Article numberCD006266
JournalThe Cochrane database of systematic reviews
Issue number4
DOIs
Publication statusPublished - 2006

Fingerprint

Sodium Oxybate
Alcohols
Appointments and Schedules
Therapeutics
Placebos
Safety
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal. / Leone, Maurizio A.; Avanzi, G. C.; Lo Iacono, A.; Vigna-Taglianti, F.; Faggiano, F.

In: The Cochrane database of systematic reviews, No. 4, CD006266, 2006.

Research output: Contribution to journalArticle

Leone, Maurizio A. ; Avanzi, G. C. ; Lo Iacono, A. ; Vigna-Taglianti, F. ; Faggiano, F. / Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal. In: The Cochrane database of systematic reviews. 2006 ; No. 4.
@article{9969b623466b4ab78d8323098b93a5ea,
title = "Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal",
abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy and safety of GHB in prevention and treatment of the AWS, more specifically • to compare the efficacy of GHB with placebo or other drugs; • to identify the most effective GHB dosage and schedules; • to estimate the incidence of side effects; • to carry out a risk-benefit analysis. ...",
author = "Leone, {Maurizio A.} and Avanzi, {G. C.} and {Lo Iacono}, A. and F. Vigna-Taglianti and F. Faggiano",
year = "2006",
doi = "10.1002/14651858.CD006266",
language = "English",
journal = "Cochrane Database of Systematic Reviews",
issn = "1361-6137",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal

AU - Leone, Maurizio A.

AU - Avanzi, G. C.

AU - Lo Iacono, A.

AU - Vigna-Taglianti, F.

AU - Faggiano, F.

PY - 2006

Y1 - 2006

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy and safety of GHB in prevention and treatment of the AWS, more specifically • to compare the efficacy of GHB with placebo or other drugs; • to identify the most effective GHB dosage and schedules; • to estimate the incidence of side effects; • to carry out a risk-benefit analysis. ...

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy and safety of GHB in prevention and treatment of the AWS, more specifically • to compare the efficacy of GHB with placebo or other drugs; • to identify the most effective GHB dosage and schedules; • to estimate the incidence of side effects; • to carry out a risk-benefit analysis. ...

UR - http://www.scopus.com/inward/record.url?scp=37649031502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37649031502&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD006266

DO - 10.1002/14651858.CD006266

M3 - Article

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

IS - 4

M1 - CD006266

ER -